Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype |hepatitis c
Sentences 119
PubMedID- 21253791 Several noncurative treatments also appear to reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 22439008 [10] stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection.
PubMedID- 25912838 We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis.
PubMedID- 23564522 The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown.
PubMedID- 24037287 In fact, diverse studies have already correlated viral exposure to epigenetic alterations and human cancer such as hepatitis b virus and hepatitis c virus with hepatocellular carcinoma1626.
PubMedID- 23860735 Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 20883676 Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection.
PubMedID- 21133598 Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection.
PubMedID- 20731020 hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis.
PubMedID- 22004425 Genetic risk of hepatocellular carcinoma in patients with hepatitis c virus: a case control study.
PubMedID- 26301052 hepatitis c infection can lead to cirrhosis and hepatocellular carcinoma and it is an important cause of mortality and morbidity.
PubMedID- 20458764 Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c.
PubMedID- 22212964 Viral hepatitis among somali immigrants in minnesota: association of hepatitis c with hepatocellular carcinoma.
PubMedID- 24772876 [concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c].
PubMedID- 24179611 Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis.
PubMedID- 23982634 Effect of occult hepatitis b virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 21931376 Frequency of elevated hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c.
PubMedID- 23099187 Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study.
PubMedID- 26469163 [feasibility and safety of dexmedetomidine sedation in transarterial embolization for hepatocellular carcinoma with hepatitis c-related cirrhosis].
PubMedID- 24081938 Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted.
PubMedID- 21718500 Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus [51].
PubMedID- 26428254 Non-alcoholic steato-hepatitis can progress to cirrhosis of the liver and hepatocellular carcinoma.
PubMedID- 21619694 Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma [49,70,75], suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor.
PubMedID- 24757565 For instance, most human hepatocellular carcinomas (hccs) result from hepatitis c virus (hcv) infection [271, 272].
PubMedID- 23426277 Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c.
PubMedID- 23689989 Il28b minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis c virus infection.
PubMedID- 24223741 Purpose: recent studies have revealed that branched-chain amino acids (bcaa) reduce the development of hepatocellular carcinoma (hcc) in patients with obesity and hepatitis c virus infection by improving insulin resistance (ir).
PubMedID- 21319193 Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c.
PubMedID- 21331763 Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 23125843 The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005).
PubMedID- 21520203 Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis c.
PubMedID- 26064707 His medical history was notable for cirrhosis secondary to chronic hepatitis c, complicated by multifocal hepatocellular carcinoma (hcc), which had been lately diagnosed following an episode of obstructive jaundice.
PubMedID- 21170963 Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc).
PubMedID- 24662676 Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes.
PubMedID- 22899800 A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy.
PubMedID- 26017875 Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus.
PubMedID- 25650331 Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 22695885 Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis.
PubMedID- 21963516 To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2890 hcv-negative controls of japanese origin.
PubMedID- 24843320 Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection.
PubMedID- 26191473 In addition, dm has been suggested to enhance the development of hepatocellular carcinoma in patients with chronic hepatitis c (kawamura et al.
PubMedID- 22911171 Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included.
PubMedID- 21766498 Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection.
PubMedID- 25373121 Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis c.
PubMedID- 21610221 Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis.
PubMedID- 23463401 hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region.
PubMedID- 23267897 A 76-year-old man, who had been treated with interferon-alpha(ifn-alpha) for hepatitis c, was diagnosed with multiple hepatocellular carcinomas (hcc; s7/8, s8, s5, s2) with right hepatic vein tumor thrombus (vv2).
PubMedID- 22066022 Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma.
PubMedID- 23602201 High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 22919246 A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis c virus patients with hepatocellular carcinoma.

Page: 1 2 3